Literature DB >> 22035595

Type 2-diabetes is associated with elevated levels of TNF-alpha, IL-6 and adiponectin and low levels of leptin in a population of Mexican Americans: a cross-sectional study.

S Mirza1, Monir Hossain, Christine Mathews, Perla Martinez, Paula Pino, Jennifer L Gay, Anne Rentfro, Joseph B McCormick, Susan P Fisher-Hoch.   

Abstract

The goal of the study was to determine the association between diabetes and inflammation in clinically diagnosed diabetes patients. We hypothesized that low-grade inflammation in diabetes is associated with the level of glucose control. Using a cross-sectional design we compared pro- and anti-inflammatory cytokines in a community-recruited cohort of 367 Mexican Americans with type 2-diabetes having a wide range of blood glucose levels. Cytokines (IL-6, TNF-α, IL-1β, IL-8) and adipokines (adiponectin, resistin and leptin) were measured using multiplex ELISA. Our data indicated that diabetes as whole was strongly associated with elevated levels of IL-6, leptin, CRP and TNF-α, whereas worsening of glucose control was positively and linearly associated with high levels of IL-6, and leptin. The associations remained statistically significant even after controlling for BMI and age (p=0.01). The association between TNF-α, however, was attenuated when comparisons were performed based on glucose control. Strong interaction effects between age and diabetes and BMI and diabetes were observed for IL-8, resistin and CRP. The cytokine/adipokine profiles of Mexican Americans with diabetes suggest an association between low-grade inflammation and quality of glucose control. Unique to in our population is that the chronic inflammation is accompanied by lower levels of leptin. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22035595      PMCID: PMC3270578          DOI: 10.1016/j.cyto.2011.09.029

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  36 in total

Review 1.  The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Arindam Bandyopadhyay
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

2.  Ethnic-specific pathways to obesity-related disease: the Hispanic vs. African-American paradox.

Authors:  Michael I Goran
Journal:  Obesity (Silver Spring)       Date:  2008-12       Impact factor: 5.002

3.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

4.  Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes.

Authors:  J C Pickup; G D Chusney; S M Thomas; D Burt
Journal:  Life Sci       Date:  2000-06-08       Impact factor: 5.037

5.  High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study.

Authors:  Na Zhu; James S Pankow; Christie M Ballantyne; David Couper; Ron C Hoogeveen; Mark Pereira; Bruce B Duncan; Maria Inês Schmidt
Journal:  J Clin Endocrinol Metab       Date:  2010-08-18       Impact factor: 5.958

6.  Relationship between leptin, adiponectin, bone mineral density, and measures of adiposity among pre-menopausal Hispanic and Caucasian women.

Authors:  George A King; Sarah E Deemer; Dixie L Thompson
Journal:  Endocr Res       Date:  2010       Impact factor: 1.720

7.  Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007.

Authors:  Susan P Fisher-Hoch; Anne R Rentfro; Jennifer J Salinas; Adriana Pérez; H Shelton Brown; Belinda M Reininger; Blanca I Restrepo; J Gaines Wilson; M Monir Hossain; Mohammad H Rahbar; Craig M Hanis; Joseph B McCormick
Journal:  Prev Chronic Dis       Date:  2010-04-15       Impact factor: 2.830

8.  Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study.

Authors:  Rodolfo J Dennis; Dario Maldonado; Maria X Rojas; Pablo Aschner; Martin Rondón; Laura Charry; Alejandro Casas
Journal:  BMC Pulm Med       Date:  2010-07-26       Impact factor: 3.317

9.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

Authors:  S Müller; S Martin; W Koenig; P Hanifi-Moghaddam; W Rathmann; B Haastert; G Giani; T Illig; B Thorand; H Kolb
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

10.  Human primary adipocytes exhibit immune cell function: adipocytes prime inflammation independent of macrophages.

Authors:  Kees Meijer; Marcel de Vries; Saad Al-Lahham; Marcel Bruinenberg; Desirée Weening; Martijn Dijkstra; Niels Kloosterhuis; Roelof Jan van der Leij; Han van der Want; Bart-Jan Kroesen; Roel Vonk; Farhad Rezaee
Journal:  PLoS One       Date:  2011-03-23       Impact factor: 3.240

View more
  88 in total

1.  The host response to poly(lactide-co-glycolide) scaffolds protects mice from diet induced obesity and glucose intolerance.

Authors:  Michael A Hendley; Kendall P Murphy; Christopher Isely; Heather L Struckman; Prakasam Annamalai; R Michael Gower
Journal:  Biomaterials       Date:  2019-06-19       Impact factor: 12.479

2.  Evaluation of IL-8 nasal lavage levels and the effects of nasal involvement on disease severity in patients with stable chronic obstructive pulmonary disease.

Authors:  Hacer Celik; Serdar Akpinar; Hayriye Karabulut; Pinar Oktar; Berna Dursun; Huyla Celenk Erguden; Sibel Gunay; Tugrul Sipit
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

3.  Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients.

Authors:  Alliny de Souza Bastos; Dana T Graves; Ana Paula de Melo Loureiro; Carlos Rossa Júnior; Sâmia Cruz Tfaile Corbi; Fausto Frizzera; Raquel Mantuaneli Scarel-Caminaga; Niels Olsen Câmara; Oelisoa M Andriankaja; Meire I Hiyane; Silvana Regina Perez Orrico
Journal:  J Diabetes Complications       Date:  2016-07-21       Impact factor: 2.852

4.  Acculturative stress and inflammation among Chinese immigrant women.

Authors:  Carolyn Y Fang; Eric A Ross; Harsh B Pathak; Andrew K Godwin; Marilyn Tseng
Journal:  Psychosom Med       Date:  2014-06       Impact factor: 4.312

Review 5.  Neurogenic obesity and systemic inflammation following spinal cord injury: A review.

Authors:  Gary J Farkas; David R Gater
Journal:  J Spinal Cord Med       Date:  2017-07-30       Impact factor: 1.985

Review 6.  SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?

Authors:  R Mahony; S Ahmed; C Diskin; N J Stevenson
Journal:  Cell Mol Life Sci       Date:  2016-05-02       Impact factor: 9.261

7.  ASSOCIATION OF TOTAL AND DIFFERENTIAL WHITE BLOOD CELL COUNTS TO DEVELOPMENT OF TYPE 2 DIABETES IN MEXICAN AMERICANS IN CAMERON COUNTY HISPANIC COHORT.

Authors:  Kristina P Vatcheva; Susan P Fisher-Hoch; Mohammad H Rahbar; MinJae Lee; Rene L Olvera; Joseph B Mccormick
Journal:  Diabetes Res       Date:  2015-09-23

8.  Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant.

Authors:  Subhadra C Gunawardana; David W Piston
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-04-21       Impact factor: 4.310

9.  Gene expression and DNA methylation changes in BeWo cells dependent on tumor necrosis factor-α and insulin-like growth factor-I.

Authors:  Kei Tanaka; Kazuhiko Nakabayashi; Tomoko Kawai; Shinji Tanigaki; Kenji Matsumoto; Kenichiro Hata; Yoichi Kobayashi
Journal:  Hum Cell       Date:  2019-11-13       Impact factor: 4.174

10.  The association between cytokines and insulin sensitivity in Iraqi immigrants and native Swedes.

Authors:  Ashfaque A Memon; Jan Sundquist; Xiao Wang; Karolina Palmér; Kristina Sundquist; Louise Bennet
Journal:  BMJ Open       Date:  2013-11-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.